{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:58:38Z","timestamp":1770713918171,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":4944,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[1993,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Epltein\u2010Barr virus (EBV) induces unlimited growth of B lymphocytes in vitro, a phenomenon known as immortalization. The elucidation of the mechanisms by which EBV de\u2010regulates 8\u2010cell protiiferation in vitro will permit an undemtanding of how the vim contributes in vivo to the genesis of Burkitt's lym\u2010 phoma (BL) and of lymphopmliierations in immunosuppressed patients. At present, no singie EBV immortalizing gene has been identified, and the hypothesis has been made that many viral genes cooperate in establishing an autocrine loop of secretion leading to irnmortdization. Constitutive expression of B\u2010cell surface molecules such as CD2l and CD23, specifically impli\u2010 cated in the control of B\u2010cell proliferation, is indeed induced at the surface of immortalized B lymphocytes. The expression of the v i d nuclear antigen 2 (EBNA2) has been shown to be in part responsible for CD2l and CD23 upregulation, and EBNA2 is suspected to be a transactivahr of cellular genes, although this point remains to be demonstrated. The role of EBNA2 gene, independently of other vim1 genes, has beeriinvestigated by transfeetion into B\u2010lymphoma lines, but conflicting results have been reported. To further investigate its role in the regulation ofCD2l and CD23 molecules, we have compared the effects of EBNA2 expression in 2 sets of B\u2010lymphoma lines infected with P3HRI EBV strain, and\/or tmnsfected with EBNA2 gene. We report here that: (i) EBNAZ expression is not a sufficient conditiw to induce CD21 and CD23 upregulation, EBNA2\u2032s effects are highly dependent on the cellular context, and momover can be modffied by infection with P3HRl virus; (ii) EBNA2 inducer acthation of CD23 expression in a very pvticutar way, namely, an increased quantity of CD23 steady\u2010 state RNA coding for the form A of the protein, which is not detectable at the cell surface but directly secreted. \u00ae 1993 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.2910530128","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T23:27:39Z","timestamp":1171927659000},"page":"153-160","source":"Crossref","is-referenced-by-count":29,"title":["Epstein\u2010barr virus (EBV) nuclear\u2010antigen\u20102\u2010induced up\u2010regulation of cd21 and cd23 molecules is dependent on a permissive cellular context"],"prefix":"10.1002","volume":"53","author":[{"given":"Martin","family":"Cordier\u2010Bussat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Billaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Calender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert M.","family":"Lenoir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60654-9"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450115"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/jvi.43.3.952-968.1982","article-title":"Deletion of a non\u2010transforming Epstein\u2010Barr Virus strain P3HR1 causes fusion of the large internal repeat to the DSL region","volume":"43","author":"Bornkamm S. W.","year":"1982","journal-title":"J. Virol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.22.8060"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910460418"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/jvi.64.3.1002-1013.1990","article-title":"Stable transfection of Epstein\u2010Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing EBVIP3HR1 genome induces expression of B\u2010cell activation molecules CD21 and CD23","volume":"64","author":"Cordier M.","year":"1990","journal-title":"J. Virol."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420516"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910380618"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/jvi.64.4.1855-1858.1990","article-title":"Cis\u2010acting regulatory elements near the Epstein\u2010Barr\u2010virus latent infection membrane protein transcriptional start site","volume":"64","author":"Ghosh D.","year":"1990","journal-title":"J. Virol"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(89)90171-0"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/310145a0"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/340393a0"},{"key":"e_1_2_1_14_1","first-page":"461","article-title":"Amino acid sequence homology of Epstein\u2010Barr virus nuclear antigen\u20102 to adenovirus ElA, human papilloma virus\u2010I6 E7 and SV40 large T antigen in the functional domains for growth transformation","volume":"6","author":"Harada S.","year":"1991","journal-title":"Oncogene"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1985.tb03854.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(08)60832-5"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.135.4.2654","article-title":"Fine specificity, structure, and proteolytic susceptibility of the human lymphocyte receptor for IgE","volume":"135","author":"Peterson L. H.","year":"1985","journal-title":"J. Immunol."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(84)90072-6"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jnci\/77.3.681","article-title":"Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines","volume":"77","author":"Rooney C. M.","year":"1986","journal-title":"J. nat. Cancer lnst."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02568.x"},{"key":"e_1_2_1_21_1","first-page":"133","volume-title":"Advances in viral oncology","author":"Speck S. H.","year":"1989"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.5.2.410"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/15.18.7295"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.1.45"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/338649a0"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/jvi.64.5.2309-2318.1990","article-title":"EBV latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA2 and LMPl cooperatively induce CD23","volume":"64","author":"Wang F.","year":"1990","journal-title":"J. Virol."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.22.10933"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.4049\/jimmunol.147.7.2404","article-title":"Identification of 5\u2032 regions affecting the expression of the human CR2 gene","volume":"147","author":"Yang M. L.","year":"1991","journal-title":"J. Immunol."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90219-X"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.2910530128","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.2910530128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T01:08:37Z","timestamp":1698282517000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.2910530128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1,2]]}},"alternative-id":["10.1002\/ijc.2910530128"],"URL":"https:\/\/doi.org\/10.1002\/ijc.2910530128","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1,2]]}}}